Endocrinology. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon ® ) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation

Author: Out Henk J.  

Publisher: Oxford University Press

ISSN: 1460-2350

Source: Human Reproduction, Vol.15, Iss.1, 2000-01, pp. : 29-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content